Archon Biosciences raised $20M in seed financing led by Madrona Ventures to advance its innovative Antibody Cage technology for drug development.
Amount Raised
$20 Million
Round Type
Seed
SeattleBiotechnologyHealth CareArtificial IntelligenceTherapeuticsInvestors
Description
Archon Biosciences, a biotechnology company, has emerged from stealth with $20 million in seed financing. The funding, led by Madrona Ventures, will be used to enhance their novel class of biologics and develop their proprietary protein design platform.
Quick answer
Archon Biosciences raised $20 Million in a Seed round, dated October 30, 2024. Investors: Alexandria Venture Investments, Dumac Inc., Sahsen Ventures, WRF Capital, Pack Ventures, Cornucopian Capital and Madrona Ventures. Archon Biosciences is based in Seattle, Washington, United States.
- How much did Archon Biosciences raise?
- Archon Biosciences raised $20 Million in a Seed round on October 30, 2024.
- Who invested in Archon Biosciences?
- Alexandria Venture Investments, Dumac Inc., Sahsen Ventures, WRF Capital, Pack Ventures, Cornucopian Capital and Madrona Ventures are named as investors in this round.
- What does Archon Biosciences do?
- Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease.
- Where is Archon Biosciences based and how big is it?
- Archon Biosciences is based in Seattle, Washington, United States.
- Who are the decision-makers at Archon Biosciences?
- Fundz holds 1 contact at Archon Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Archon Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Orakl Oncology raised $12M (Seed) on December 3, 2024.
- Pathos AI raised $62M (Series C) on October 29, 2024.
- Pathos AI raised $62M on October 24, 2024.
- Shift Bioscience raised $16M (Seed) on October 15, 2024.
- BioSapien raised $5.5M (Series A) on December 13, 2024.
- Vivid Mind raised $200K (Pre-Seed) on December 13, 2024.
Who to call at Archon Biosciences, and when
A new round usually means Archon Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Archon Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Archon Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Archon Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Archon Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Archon Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.